Literature DB >> 15099893

Chronic obstructive pulmonary disease: are women more susceptible than men?

Kenneth R Chapman1.   

Abstract

Current data show that women now suffer from COPD at least as commonly as men. They seem to be more predisposed to suffer the adverse respiratory consequences of tobacco smoking with the development of COPD at an earlier age and with a greater degree of lung function impairment for a given amount of tobacco exposure. This may be explained, in part, by women's greater airway responsiveness to exogenous stimuli--an increased responsiveness that is explained largely by differences in lung size and geometry. Hormonal factors and immunologic factors that influence the lung also may differ between the sexes but their significance is poorly understood. Despite the increasing prevalence of COPD among women, their disease is more likely to be overlooked as compared with the same disease in men. This gender bias in diagnosis is not likely to be remedied until physicians begin to use spirometric testing to screen for this common disease. Women who smoke may have greater difficulty quitting than men. There are documented differences in health care use between men and women who have COPD, but too few studies have been done to allow conclusions to be drawn about the impact of sex and gender on the prognosis of the disease.

Entities:  

Mesh:

Year:  2004        PMID: 15099893     DOI: 10.1016/j.ccm.2004.01.003

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  23 in total

Review 1.  Endocrine regulation of lung disease and inflammation.

Authors:  Nathalie Fuentes; Patricia Silveyra
Journal:  Exp Biol Med (Maywood)       Date:  2018-12-03

2.  Gender and chronic obstructive pulmonary disease: why it matters.

Authors:  Meilan K Han; Dirkje Postma; David M Mannino; Nicholas D Giardino; Sonia Buist; Jeffrey L Curtis; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2007-08-02       Impact factor: 21.405

Review 3.  Pharmacotherapy for smoking cessation: current advances and research topics.

Authors:  Tobias Raupach; Constant P van Schayck
Journal:  CNS Drugs       Date:  2011-05       Impact factor: 5.749

4.  Prevalence of chronic obstructive pulmonary disease among stable chronic disease subjects in primary care in Trinidad, West Indies.

Authors:  Peterson Thorington; Maria Rios; Gina Avila; Josia Henry; C Haynes; Lexley M Pinto Pereira; Terence Ar Seemungal
Journal:  J Thorac Dis       Date:  2011-09       Impact factor: 2.895

Review 5.  Sex differences and sex steroids in lung health and disease.

Authors:  Elizabeth A Townsend; Virginia M Miller; Y S Prakash
Journal:  Endocr Rev       Date:  2012-01-12       Impact factor: 19.871

6.  Sex Hormones and Lung Inflammation.

Authors:  Jorge Reyes-García; Luis M Montaño; Abril Carbajal-García; Yong-Xiao Wang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 7.  Improving the differential diagnosis of chronic obstructive pulmonary disease in primary care.

Authors:  David B Price; Barbara P Yawn; Rupert C M Jones
Journal:  Mayo Clin Proc       Date:  2010-12       Impact factor: 7.616

8.  Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary disease.

Authors:  M C Matheson; G Benke; J Raven; M R Sim; H Kromhout; R Vermeulen; D P Johns; E H Walters; M J Abramson
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

Review 9.  Human immunodeficiency virus-associated obstructive lung diseases.

Authors:  Matthew R Gingo; Alison Morris; Kristina Crothers
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

10.  Smoking and smoking cessation in relation to the development of co-existing non-small cell lung cancer with chronic obstructive pulmonary disease.

Authors:  Rihong Zhai; Xiaojin Yu; Yongyue Wei; Li Su; David C Christiani
Journal:  Int J Cancer       Date:  2013-08-29       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.